We are live on ! Find out more
CLPT icon

ClearPoint Neuro

56 hedge funds and large institutions have $39.6M invested in ClearPoint Neuro in 2022 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 10

67% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 9

12% more call options, than puts

Call options by funds: $2.1M | Put options by funds: $1.87M

12% more funds holding

Funds holding: 5056 (+6)

0.93% more ownership

Funds ownership: 14.69%15.62% (+0.93%)

13% less capital invested

Capital invested by funds: $45.4M → $39.6M (-$5.83M)

Holders
56
Holders Change
+6
Holders Change %
+12%
% of All Funds
0.96%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
15
Increased
18
Reduced
10
Closed
9
Calls
$2.1M
Puts
$1.87M
Net Calls
+$225K
Net Calls Change
-$1.93M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$10.2M +$103K +7,806 +0.8%
BlackRock
2
BlackRock
New York
$4.28M +$1.52M +115,127 +39%
Brown Advisory
3
Brown Advisory
Maryland
$3.4M
Geode Capital Management
4
Geode Capital Management
Massachusetts
$2.23M +$575K +43,637 +25%
TFCM
5
Taylor Frigon Capital Management
Arizona
$1.85M +$53.4K +4,054 +2%
EIM
6
Essex Investment Management
Massachusetts
$1.75M +$835K +63,349 +60%
CWM
7
Cahill Wealth Management
Michigan
$1.37M +$432K +32,816 +33%
CM
8
CM Management
Florida
$1.24M -$65.9K -5,000 -4%
CCM
9
Conway Capital Management
California
$1.18M +$350K +26,559 +30%
EI
10
EAM Investors
California
$1.17M +$334K +25,337 +29%
PCM
11
Parsons Capital Management
Rhode Island
$1.14M +$290 +22 +0%
Morgan Stanley
12
Morgan Stanley
New York
$1.07M -$317K -24,047 -19%
Millennium Management
13
Millennium Management
New York
$1.06M -$1.16M -88,397 -46%
Commonwealth Equity Services
14
Commonwealth Equity Services
Massachusetts
$862K +$174K +13,230 +19%
E
15
Ergoteles
New York
$739K -$266K -20,178 -22%
State Street
16
State Street
Massachusetts
$581K +$3.95K +300 +0.5%
Assenagon Asset Management
17
Assenagon Asset Management
Luxembourg
$528K +$671K +50,935 New
UBS Group
18
UBS Group
Switzerland
$386K +$463K +35,157 +1,669%
Goldman Sachs
19
Goldman Sachs
New York
$370K -$122K -9,237 -21%
SAM
20
Silvercrest Asset Management
New York
$370K
Northern Trust
21
Northern Trust
Illinois
$364K +$54.1K +4,106 +13%
SL
22
Sentinus LLC
Illinois
$363K +$462K +35,050 New
LPL Financial
23
LPL Financial
California
$348K +$23.4K +1,775 +6%
JP Morgan Chase
24
JP Morgan Chase
New York
$340K -$9.2K -698 -2%
Citadel Advisors
25
Citadel Advisors
Florida
$277K -$110K -8,342 -24%

CLPT Hedge Fund Activity: Q3 2022 in Review

56 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q3 2022, worth a combined $39.6M — down 13% from $45.4M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new CLPT positions and 9 closed out — a net gain of 6 holders — while 18 added to existing stakes and 10 trimmed.

The largest buyer was BlackRock, adding an estimated $1.52M. The largest seller was Millennium Management, cutting an estimated $1.16M.

  • 56 institutional investors held ClearPoint Neuro (CLPT) as of Q3 2022, up from 50 in Q2 2022.
  • Funds reported $39.6M of ClearPoint Neuro stock for Q3 2022, down 13% quarter-over-quarter.
  • 15 funds opened new ClearPoint Neuro positions in Q3 2022 and 9 closed out, a net change of +6 holders.
  • The largest ClearPoint Neuro buyer in Q3 2022 was BlackRock, an estimated $1.52M added.
  • The largest ClearPoint Neuro seller in Q3 2022 was Millennium Management, an estimated $1.16M sold.

Based on aggregated 13F filings for Q3 2022.